THE CHANGING LANDSCAPE OF HIV-ASSOCIATED CARDIOVASCULAR DISEASE IN THE ANTI RETRO VIRAL THERAPY ERA

Human Immunodeficiency Virus (HIV) once recognized to cause immune deficient state in the infected person. Due to advent of Anti Retro Viral Therapy(ART) Its now being increasingly recognized as a Chronic condition. This Review Article focuses on clinical care that has been altered in a way that is unusual for a disease. Opportunistic infections and illnesses associated with an immunocompromised state dominated in the early phases of the epidemic, and a large corpus of research and therapeutic practice centered on these sequelae. In the present treatment period, HIV patients on suppressive antiretroviral medication face a new set of problems. These chronic, non-infectious disorders, such as cardiovascular disease (CVD), require management approaches that are distinct from those used to treat infectious consequences. An HIV-positive patient's optimal care for cardiovascular disease and other non-infectious consequences may differ from that of a healthy person. New research into the epidemiology, pathophysiology, prevention, and treatment of chronic illness problems, as well as the translation of such research into guidelines and policy creation, is needed as the focus of care for stable treatment for HIV-infected individuals.